Results 161 to 170 of about 31,870 (205)
Some of the next articles are maybe not open access.
Infectious Disease Clinics of North America, 2019
Visceral Leishmaniasis ...
Johan Van Griensven, Ermias Diro
exaly +3 more sources
Visceral Leishmaniasis ...
Johan Van Griensven, Ermias Diro
exaly +3 more sources
Treatment of visceral leishmaniasis
Expert Opinion on Pharmacotherapy, 2005The Leishmania donovani complex includes L. chagasi and L. infantum, and causes visceral leishmaniasis (VL), a disseminated and potentially fatal form of leishmaniasis. The treatment options for VL are limited. Pentavalent antimonials (Sbv) are the first-line treatment options worldwide except for in Europe and Sbv-unresponsive regions of India ...
, Madhukar Rai
exaly +3 more sources
Gastroenterology Clinics of North America, 1996
Visceral leishmaniasis presents a serious problem in endemic regions that is difficult to treat or prevent. Several epidemiologic problems make the disease particularly troublesome to manage. These include the facts that classic visceral leishmaniasis is fatal if untreated and there is not reliable access to medical care in many endemic regions.
M E, Wilson, J A, Streit
openaire +3 more sources
Visceral leishmaniasis presents a serious problem in endemic regions that is difficult to treat or prevent. Several epidemiologic problems make the disease particularly troublesome to manage. These include the facts that classic visceral leishmaniasis is fatal if untreated and there is not reliable access to medical care in many endemic regions.
M E, Wilson, J A, Streit
openaire +3 more sources
Visceral leishmaniasis in paediatrics
Current Opinion in Infectious Diseases, 2002Visceral leishmaniasis is a vector-borne systemic infection, which affects half a million people each year in many areas of the world. Typical disease manifests with fever, hepatosplenomegaly, pancytopenia, and progressive deterioration of the host. Although molecular methods appear promising as a non-invasive diagnostic tool, definite diagnosis still ...
Dimitris A, Kafetzis, Helen C, Maltezou
openaire +2 more sources
Mediterranean Visceral Leishmaniasis in Pregnancy
Scandinavian Journal of Infectious Diseases, 1994Visceral leishmaniasis (VL) in pregnancy is rare in Mediterranean countries. We report here 2 cases of VL in pregnant women who acquired the infection in Italy. In the first case, the disease was diagnosed and treated with liposomal amphotericin B during the pregnancy.
GRADONI L +4 more
openaire +3 more sources
Drug combinations for visceral leishmaniasis
Current Opinion in Infectious Diseases, 2010Several attempts have been made to combine drugs for treating visceral leishmaniasis, but only recently have effective drugs become available and combinations been tested systematically.Sequential treatments with liposomal amphotericin B followed by miltefosine or paromomycin (as short as 7 days), as well as the concomitant administration of ...
openaire +3 more sources